SCHEMBL26041296

SCHEMBL26041296

N#Cc1ccccc1-c1ccc(-c2nc(-c3ccc(-c4ccccc4C#N)cc3-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)nc(-c3ccc(-c4ccccc4C#N)cc3-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.40
CYP1A2 P05177 6/20 0.38
CYP3A4 P08684 6/20 0.38
HSD17B10 Q99714 4/20 0.38
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38
TRPA1 O75762 1/20 0.38
MAPT P10636 1/20 0.38
ESR2 Q92731 1/20 0.37
CLK4 Q9HAZ1 3/20 0.37
MAPK1 P28482 2/20 0.37
GABRG2 P18507 3/20 0.37
GABRB3 P28472 3/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
ALOX5AP P20292 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24923987 0.99 NR3C1 (0.40) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26052194 0.97 TRPA1 (0.38) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26051637 0.95 ABCG2 (0.37) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26052093 0.95 CYP1A2 (0.38) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26041327 0.95 NR3C1 (0.39) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26051639 0.94 ABCG2 (0.37) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL20904943 0.94 NR3C1 (0.48) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26055944 0.94 NR3C1 (0.38) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26051961 0.93 CYP1A2 (0.39) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL26041180 0.93 CYP1A2 (0.39) NR3C1CYP1A2CYP3A4HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 NR3C1 1315/4885CYP1A2 236/4885CYP3A4 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.